Biering-Sorensen, T., Shah, A., Claggett, B., Zile, M., Pieske, B., Pieske-Kraigher, E., … Solomon, S. (2018). THE ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR (ARNI), SACUBITRIL/VALSARTAN, IMPROVES LEFT VENTRICULAR MYOCARDIAL DEFORMATION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (PARAMOUNT TRIAL). Journal of the American College of Cardiology, 71(11), A2665–A2665. https://doi.org/10.1016/s0735-1097(18)33206-6

Biering-Sorensen, Tor, Amil Shah, Brian Claggett, Michael Zile, Burkert Pieske, Elisabeth Pieske-Kraigher, Adriaan Voors, et al. “THE ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR (ARNI), SACUBITRIL/VALSARTAN, IMPROVES LEFT VENTRICULAR MYOCARDIAL DEFORMATION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (PARAMOUNT TRIAL).” Journal of the American College of Cardiology 71, no. 11 (March 2018): A2665–A2665. https://doi.org/10.1016/s0735-1097(18)33206-6.

Biering-Sorensen T, Shah A, Claggett B, Zile M, Pieske B, Pieske-Kraigher E, et al. THE ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR (ARNI), SACUBITRIL/VALSARTAN, IMPROVES LEFT VENTRICULAR MYOCARDIAL DEFORMATION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (PARAMOUNT TRIAL). Journal of the American College of Cardiology. 2018 Mar;71(11):A2665–A2665.

Biering-Sorensen, Tor, et al. “THE ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR (ARNI), SACUBITRIL/VALSARTAN, IMPROVES LEFT VENTRICULAR MYOCARDIAL DEFORMATION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (PARAMOUNT TRIAL).” Journal of the American College of Cardiology, vol. 71, no. 11, Elsevier BV, Mar. 2018, pp. A2665–A2665. Crossref, doi:10.1016/s0735-1097(18)33206-6.

Biering-Sorensen T, Shah A, Claggett B, Zile M, Pieske B, Pieske-Kraigher E, Voors A, Shi V, Lefkowitz M, Packer M, McMurray JJV, Solomon S. THE ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR (ARNI), SACUBITRIL/VALSARTAN, IMPROVES LEFT VENTRICULAR MYOCARDIAL DEFORMATION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (PARAMOUNT TRIAL). Journal of the American College of Cardiology. Elsevier BV; 2018 Mar;71(11):A2665–A2665.